FDA Inspection 1166601 — Neelam Dhiman, PhD
The FDA completed an inspection of Neelam Dhiman, PhD on Mar 30, 2022 in Lewisville, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 30, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lewisville, TX (United States)
Additional Details
Clinical Investigator (CI)